LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D.
LeonaBio, a clinical-stage biopharmaceutical company, announced the appointment of Fred Callori, J.D., Natalie Holles, and Peter B. Silverman, J.D. to its Board of Directors. These new members bring extensive experience in drug development, corporate strategy, and capital markets, aligning with LeonaBio’s focus on oncology and neurology therapeutic…